ZA904413B - Intravaginal treatment of vaginal infections with buffered metronidazole compositions - Google Patents

Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Info

Publication number
ZA904413B
ZA904413B ZA904413A ZA904413A ZA904413B ZA 904413 B ZA904413 B ZA 904413B ZA 904413 A ZA904413 A ZA 904413A ZA 904413 A ZA904413 A ZA 904413A ZA 904413 B ZA904413 B ZA 904413B
Authority
ZA
South Africa
Prior art keywords
metronidazole
vaginal infections
buffered
composition
treatment
Prior art date
Application number
ZA904413A
Other languages
English (en)
Inventor
Robert J Borgman
J Borgman Robert
Original Assignee
Curatek Pharmaceuticals
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Curatek Pharmaceuticals filed Critical Curatek Pharmaceuticals
Priority to ZA904413A priority Critical patent/ZA904413B/xx
Publication of ZA904413B publication Critical patent/ZA904413B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/04Amoebicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA904413A 1989-06-06 1990-06-07 Intravaginal treatment of vaginal infections with buffered metronidazole compositions ZA904413B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA904413A ZA904413B (en) 1989-06-06 1990-06-07 Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36227389A 1989-06-06 1989-06-06
ZA904413A ZA904413B (en) 1989-06-06 1990-06-07 Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Publications (1)

Publication Number Publication Date
ZA904413B true ZA904413B (en) 1991-04-24

Family

ID=23425444

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA904413A ZA904413B (en) 1989-06-06 1990-06-07 Intravaginal treatment of vaginal infections with buffered metronidazole compositions

Country Status (21)

Country Link
EP (1) EP0404376B1 (da)
JP (1) JP2999820B2 (da)
KR (1) KR0169487B1 (da)
CN (1) CN1054507C (da)
AT (1) ATE103176T1 (da)
AU (1) AU635752B2 (da)
BR (1) BR9006793A (da)
CA (1) CA1337279C (da)
DE (1) DE69007547T2 (da)
DK (1) DK0404376T3 (da)
ES (1) ES2062366T3 (da)
HU (1) HU207795B (da)
IE (1) IE65413B1 (da)
IL (1) IL94619A (da)
PH (1) PH30718A (da)
PL (1) PL164128B1 (da)
RO (1) RO109156B1 (da)
RU (1) RU2032402C1 (da)
WO (1) WO1990014832A1 (da)
YU (1) YU47950B (da)
ZA (1) ZA904413B (da)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5592949A (en) * 1994-06-29 1997-01-14 Moench; Thomas R. Device for acidic buffering and method for inactivation of pathogens
GB9610359D0 (en) * 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
GB9626513D0 (en) * 1996-12-20 1997-02-05 Bioglan Ireland R & D Ltd A pharmaceutical composition
RU2154477C1 (ru) * 1998-12-10 2000-08-20 Новокузнецкий государственный институт усовершенствования врачей Способ лечения хронического трихомониаза
RU2195943C2 (ru) * 2000-02-14 2003-01-10 Владивостокский государственный медицинский университет Способ лечения гонореи
RU2195945C2 (ru) * 2000-02-14 2003-01-10 Владивостокский государственный медицинский университет Способ лечения инфекций, передаваемых половым путем
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
DE10114244A1 (de) * 2001-03-22 2002-10-02 Heraeus Kulzer Gmbh & Co Kg Antibiotikum-/Antibiotika-Zubereitung mit retardierender Wirkstofffreisetzung
US6951654B2 (en) * 2001-03-27 2005-10-04 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of an antimicrobial agent
RU2180567C1 (ru) * 2001-05-03 2002-03-20 Новокузнецкий государственный институт усовершенствования врачей Способ лечения хронического рецидивирующего трихомониаза
RU2212238C2 (ru) * 2001-11-05 2003-09-20 Новокузнецкий государственный институт усовершенствования врачей Способ лечения рецидивирующего урогенитального кандидоза на фоне трихомониаза
GB0130666D0 (en) * 2001-12-21 2002-02-06 Accantla Holdings Ltd Absorbent tampons
US6899890B2 (en) * 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
RU2221574C2 (ru) * 2002-03-21 2004-01-20 Саратовский государственный медицинский университет Способ лечения хронического трихомонадного эндоцервицита
CA2484318C (en) * 2002-05-01 2014-01-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant antifungal gel compositions
US7005408B2 (en) * 2002-05-01 2006-02-28 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7658941B2 (en) 2002-05-01 2010-02-09 Johnson & Johnson Consumer Companies, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7695730B2 (en) 2002-05-01 2010-04-13 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
US7417013B2 (en) 2002-05-01 2008-08-26 Mcneil-Ppc, Inc. Warming and nonirritating lubricant compositions and method of comparing irritation
WO2003092652A1 (en) * 2002-05-01 2003-11-13 Mcneil-Ppc, Inc. Warming and nonirritating anhydrous lubricant compositions
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US8486376B2 (en) 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US8119150B2 (en) 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050186142A1 (en) * 2002-10-25 2005-08-25 Foamix Ltd. Kit and composition of imidazole with enhanced bioavailability
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
RU2240781C1 (ru) * 2003-06-05 2004-11-27 Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии Способ лечения воспалительных процессов вульвы и влагалища
ES2752773T3 (es) * 2003-06-13 2020-04-06 Idh Holding Aps Tratamiento de los síntomas asociados a la vaginosis bacteriana
RU2236851C1 (ru) * 2003-06-16 2004-09-27 Красноярская государственная медицинская академия Способ местного лечения бактериального вагиноза
US8486374B2 (en) 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US20060140990A1 (en) * 2003-09-19 2006-06-29 Drugtech Corporation Composition for topical treatment of mixed vaginal infections
AU2004274000B2 (en) * 2003-09-19 2009-07-30 Drugtech Corporation Pharmaceutical delivery system
RU2249821C1 (ru) * 2004-04-27 2005-04-10 Государственное учреждение "Московский научно-исследовательский институт эпидемиологии и микробиологии им. Г.Н. Габричевского Министерства здравоохранения Российской Федерации" Способ оценки микробиоценоза влагалища
MXPA04007681A (es) * 2004-07-08 2006-01-12 Drugtech Corp Sistema de liberacion.
RU2275918C1 (ru) * 2005-01-11 2006-05-10 ГОУ ВПО "Красноярская государственная медицинская академия Министерства здравоохранения РФ" Способ лечения хронического сальпингоофорита
US7851419B2 (en) 2005-09-12 2010-12-14 Nawaz Ahmad Substantially anhydrous sprayable personal lubricant
US20070059250A1 (en) * 2005-09-12 2007-03-15 Nawaz Ahmad Sprayable personal lubricant
WO2007079391A2 (en) * 2006-01-05 2007-07-12 Drugtech Corporation Drug delivery system for bioadhesion to a vulvovaginal surface
CN101374501A (zh) * 2006-01-05 2009-02-25 药物技术公司 组合物及其使用方法
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
RU2356535C2 (ru) * 2007-07-23 2009-05-27 Закрытое Акционерное Общество "Биокад" Суппозитории комбинированного действия для лечения инфекционных гинекологических заболеваний (варианты)
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009069006A2 (en) 2007-11-30 2009-06-04 Foamix Ltd. Foam containing benzoyl peroxide
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
CA2712120A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
EP2385821B1 (en) * 2009-01-09 2016-08-31 Egis Gyógyszergyár Zrt. Improved pharmaceutical formulation
US20120087872A1 (en) 2009-04-28 2012-04-12 Foamix Ltd. Foamable Vehicles and Pharmaceutical Compositions Comprising Aprotic Polar Solvents and Uses Thereof
WO2011013008A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US10029013B2 (en) 2009-10-02 2018-07-24 Foamix Pharmaceuticals Ltd. Surfactant-free, water-free formable composition and breakable foams and their uses
RU2428173C1 (ru) * 2010-06-03 2011-09-10 Общество с ограниченной ответственностью "ЦитоНИР" (ООО "ЦитоНИР") Фармацевтическая композиция для лечения заболеваний нижнего отдела мочеполовой системы
JP5986632B2 (ja) 2011-06-28 2016-09-06 メディシス ファーマシューティカル コーポレイション 高用量粘膜接着性メトロニダゾール水系ゲル製剤および細菌性膣炎を治療するためのそれらの使用
US9446024B2 (en) 2013-06-25 2016-09-20 UNIVERSITé LAVAL Formulations for the treatment of vaginal disorders
MX377365B (es) 2016-09-08 2025-03-10 Journey Medical Corp Composiciones y métodos para tratar rosácea y acné.
RU2730021C1 (ru) * 2019-10-08 2020-08-14 Общество с ограниченной ответственностью "Научно-производственная фирма ВЕРТА" Средство местного применения для лечения инфекционных вагинитов
CN112773780A (zh) * 2019-11-11 2021-05-11 深圳优丽康生物技术有限公司 一种阴道外阴用组合物及其用途
RU2726123C1 (ru) * 2019-12-20 2020-07-09 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Способ лечения трихомониаза у женщин
US11529346B2 (en) * 2020-06-18 2022-12-20 National Medical Supply, LLC Vaginal gel
WO2022006298A1 (en) * 2020-06-30 2022-01-06 Vireo Systems, Inc. Compositions for controlling odor and itch and methods of and devices for administering same
CN115737551B (zh) * 2022-12-06 2025-08-05 天津市保灵动物保健品有限公司 一种氟苯尼考甲硝唑滴耳液及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0024023B2 (de) * 1979-08-11 1992-11-11 Bayer Ag Antimykotische Mittel mit höherer Freisetzung der Wirkstoffe
US4602040A (en) * 1983-04-18 1986-07-22 Warner-Lambert Company Meclofenamic acid topical pharmaceutical composition
US4837378A (en) * 1986-01-15 1989-06-06 Curatek Pharmaceuticals, Inc. Topical metronidazole formulations and therapeutic uses thereof
GB8607159D0 (en) * 1986-03-22 1986-04-30 Smith & Nephew Ass Pharmaceutical composition
SE8603338D0 (sv) * 1986-08-07 1986-08-07 Bjorn Andersch Medel for behandling av tillstand i slidan

Also Published As

Publication number Publication date
HUT56490A (en) 1991-09-30
EP0404376A2 (en) 1990-12-27
BR9006793A (pt) 1991-08-06
AU5829490A (en) 1991-01-07
ATE103176T1 (de) 1994-04-15
EP0404376B1 (en) 1994-03-23
DE69007547D1 (de) 1994-04-28
AU635752B2 (en) 1993-04-01
HU904720D0 (en) 1991-07-29
CA1337279C (en) 1995-10-10
KR920700032A (ko) 1992-02-19
RU2032402C1 (ru) 1995-04-10
JP2999820B2 (ja) 2000-01-17
RO109156B1 (ro) 1994-12-30
PH30718A (en) 1997-09-23
PL164128B1 (pl) 1994-06-30
CN1054507C (zh) 2000-07-19
HU207795B (en) 1993-06-28
IE65413B1 (en) 1995-10-18
IE902011L (en) 1990-12-06
KR0169487B1 (ko) 1999-01-15
EP0404376A3 (en) 1991-06-05
DK0404376T3 (da) 1994-05-24
IL94619A (en) 1995-01-24
YU47950B (sh) 1996-07-24
DE69007547T2 (de) 1994-07-14
WO1990014832A1 (en) 1990-12-13
CN1049101A (zh) 1991-02-13
YU170090A (sh) 1994-04-05
JPH04500365A (ja) 1992-01-23
IL94619A0 (en) 1991-04-15
ES2062366T3 (es) 1994-12-16
PL285507A1 (en) 1992-01-13

Similar Documents

Publication Publication Date Title
ZA904413B (en) Intravaginal treatment of vaginal infections with buffered metronidazole compositions
US5905092A (en) Topical antibiotic composition providing optimal moisture environment for rapid wound healing that reduces skin contraction
EP0266968A3 (en) Gelled ointment of vasodilating agent
AU1223199A (en) Pharmaceutical formulation for stimulating the growth of gram-positive bacilli and increasing the acidity in vagina and the use thereof
IL101269A0 (en) Tacky hydrophilic gel dressings and their preparation
IE812025L (en) Composition for treating osteitis
CA2159730A1 (en) Ionene polymers as anthelmintics in animals
KR970705392A (ko) 신규한 항생제 조성물 및 그람-양성 세균 및 마이코플라스마 감염의 치료 방법(novel antibiotic compounds and methods to treat grampositive bacterial and mycoplasmal infections)
AU2002350115A1 (en) Medical compositions for intravesical treatment of bladder cancer
CA2254682A1 (en) Method of treating eye infections with azithromycin
ES8302742A1 (es) Procedimiento para preparar polimeros organicos sililados
FR2542616B1 (fr) Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
CA2221900A1 (en) Use of trospium chloride and 2-component system for the same
EP0305744A3 (en) Quinoline, naphthyridine and benzoxazine-carboxylic acid derivatives and their use as antibacterial agents
GR3036822T3 (en) Eye lotion in particular for dry eye treatment
HU901897D0 (en) Process for producing medical preparations suitable for treating vaginal infection
ES8705900A1 (es) Procedimiento para producir un polimero de formacion de hi- drogel
EP0093484A3 (en) Antibacterial monic acid derivatives
Schleicher et al. Perioperative antibiotic prophylaxis in vascular surgery.
Suter et al. Prophylactic antibiotics for hysterectomy
UA13697A1 (uk) Спосіб передпосівhої обробки hасіhhя
FR2648458B1 (fr) Acide diallyloxyacetique et ses sels d'addition basiques, leur procede de preparation et leur application comme agent reticulant
BG51775A1 (en) METHOD FOR TREATING OF ANAEMIC SYNDROME WITH HUMAN RECOMBINANT ERYTHROPOIETIN (ß)